New SARS-CoV-2 Whole...
24th November 2021 Content supplied by: Microbiologics, Inc.
Microbiologics Has Named Greg Swanson as Vice President of Sales and Marketing
Microbiologics, a medical device and life science leader providing biological materials and contract research services, has named Greg Swanson as Vice President of Sales and Marketing. Swanson will lead the global sales, business development and marketing functions to drive future growth and profitability. He has over 25 years of sales and marketing leadership experience in the medical device industry.
“Greg’s industry expertise, strategic vision and proven leadership will be a powerful combination for expanding our revenue streams, leveraging key partnerships and driving new product development to service evolving market needs,” said Microbiologics Chief Executive Officer, Brad Goskowicz. “I look forward to seeing his leadership make an impact across our organization,” Goskowicz added.
Swanson holds a Master of Business Administration from Northeastern University. His career includes marketing and sales leadership roles at Boston Scientific, Cantel Medical (Steris) and most recently as Chief Marketing Officer for Ambu A/S residing in Copenhagen, Denmark. “The thing that excites me most about joining the Microbiologics team is how broadly the company is impacting health and safety across the globe. Our role is quiet, but critical as a leading provider of the highest quality biomaterials for creating a safer, healthier world. Ninety-nine percent of the population may never know the Microbiologics name, but the world rests easier because we’re here.”
Goskowicz commented, “Microbiologics has a solid reputation for precision and convenience with our retail microbial controls for clinical diagnostic and industrial quality control. Greg’s experience in medical device development will help us maintain that market leadership, while expanding our CRO partnerships with pharmaceutical companies and pursuing opportunities in adjacent markets.”
Visit Microbiologics or click on the Request Information button below
Date Published: 24th November 2021
Source article link: View
New SARS-CoV-2 Whole Virus Antigen